Education
About Us
Working with TipRanks
Follow Us
Getinge AB (GNGBY)
:GNGBY
Earnings Data
Report Date
Jul 18, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
―Last Year’s EPS
0.18Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 22, 2025
|% Change Since: -5.19%
|Next Earnings Date:Jul 18, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a generally positive outlook with strong growth in order intake and sales, improved margins, and successful product launches. However, challenges such as currency headwinds, Life Science segment issues, and geopolitical uncertainties due to tariffs are notable concerns.Company Guidance
In the Getinge Q1 2025 call, the company presented a strong performance with key metrics highlighting a 7.1% increase in order intake and a 10.7% rise in net sales, with 6.2% coming from organic growth. The adjusted gross and EBITDA margins improved by approximately 1 percentage point, primarily due to volume leverage, acquisitions, and favorable pricing. The company reported an adjusted gross profit of SEK 4.337 billion, and an adjusted EBITDA margin that increased to 12.1%. Despite currency headwinds, Getinge maintained solid financial leverage with net debt at SEK 9.7 billion and a leverage ratio of 1.4x adjusted EBITDA, below their internal threshold. They also highlighted a decrease in their CO2 footprint, positive trends in quality KPIs, and the successful integration and growth of recent acquisitions like Paragonix. The outlook for 2025 remains unchanged, with expected organic net sales growth between 2% to 5%.Strong Order Intake and Sales Growth
Order intake grew by 7.1% with 2.9% organic growth, and net sales increased by 10.7% with 6.2% organic growth. This growth was largely driven by Acute Care Therapies and strong performance in the Americas.
Improved Margins and Financial Stability
Adjusted gross and EBITDA margins improved by about 1 percentage point, with financial leverage remaining stable despite increased net debt from acquisitions.
Sustainability Efforts Showing Results
Positive trends in sustainability KPIs, including a reduction in the CO2 footprint and improved product quality metrics.
Successful Product Launches
The KidneyVault product launched successfully with positive feedback, and EU MDR approval was obtained for the majority of products, aiding expansion outside the U.S.
Recurring Revenue and High-Margin Products
Recurring revenue now makes up 65% of sales, with high-margin products accounting for about two-thirds of revenue.
Strategic Acquisitions Support Growth
Recent acquisitions are expected to contribute an additional 2% growth in 2025.
---
GNGBY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
GNGBY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Apr 22, 2025 | $20.05 | $19.01 | -5.19% |
| Jan 28, 2025 | $18.20 | $20.08 | +10.33% |
| Oct 18, 2024 | $19.65 | $18.65 | -5.09% |
| Jul 18, 2024 | $17.51 | $19.37 | +10.62% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Getinge AB (GNGBY) report earnings?
Getinge AB (GNGBY) is schdueled to report earning on Jul 18, 2025, TBA Not Confirmed.
What is Getinge AB (GNGBY) earnings time?
Getinge AB (GNGBY) earnings time is at Jul 18, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GNGBY EPS forecast?
Currently, no data Available
---